Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue - Other
Ratios

Aclaris Therapeutics (ACRS) Leases: 2019-2020

Historic Leases for Aclaris Therapeutics (ACRS) over the last 2 years, with Sep 2020 value amounting to $435,000.

  • Aclaris Therapeutics' Leases changed negligibly% to $435,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $435,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $435,000 for FY2019, which is N/A change from last year.
  • Latest data reveals that Aclaris Therapeutics reported Leases of $435,000 as of Q3 2020, which was down 0.00% from $435,000 recorded in Q2 2020.
  • In the past 5 years, Aclaris Therapeutics' Leases ranged from a high of $2.6 million in Q1 2019 and a low of $435,000 during Q3 2019.
  • For the 2-year period, Aclaris Therapeutics' Leases averaged around $1.0 million, with its median value being $435,000 (2020).
  • Data for Aclaris Therapeutics' Leases shows a maximum YoY plummeted of 82.99% (in 2020) over the last 5 years.
  • Over the past 2 years, Aclaris Therapeutics' Leases (Quarterly) stood at $435,000 in 2019, then remained steady at $435,000 in 2020.
  • Its Leases stands at $435,000 for Q3 2020, versus $435,000 for Q2 2020 and $435,000 for Q1 2020.